What is the primary objective of NIS2?

The primary objective of NIS2 is to achieve a high common level of cybersecurity and resilience across EU member states by strengthening risk management, incident reporting, and governance for critical infrastructure and digital services. It expands beyond the original NIS Directive to cover sectors like energy, transport, public administration, cloud computing, and online marketplaces, mandating an "all-hazards" approach to threats including supply chain risks and advanced persistent threats.

Who is legally or professionally required to comply with NIS2?

NIS2 applies to all medium-sized and large essential entities (250+ employees, €50M+ turnover, or €43M+ balance sheet) and important entities (50+ employees, €10M+ turnover, or €10M+ balance sheet) in covered sectors across the EU. A size-cap rule includes all such entities regardless of prior classification, with exceptions overridden if an entity is a sole provider of critical services; sectors encompass energy, transport, health, digital infrastructure, waste management, postal services, and food production.

Does NIS2 require an external audit or third-party certification?

NIS2 does not mandate external audits or third-party certification but empowers national authorities and CSIRTs to conduct live spot checks and demand real-time evidence of compliance. Organizations must maintain continuous, auditable records of risk management, incident response, and supply chain security, shifting from static "box-ticking" to evidence-based assurance, with registration required via central authorities providing details like sector classification and operational member states.

How often should an assessment for NIS2 be performed?

NIS2 requires ongoing, continuous risk assessments rather than fixed intervals, with dynamic risk registers and asset inventories (including OT/IT) updated quarterly or as threats evolve. Entities must implement proactive measures like regular vulnerability scans, supply chain reviews, and closed-loop improvements to ensure resilience, supporting strict incident reporting timelines: early warning within 24 hours, detailed notification within 72 hours, and final report within one month.

What are the consequences of non-compliance with NIS2?

Non-compliance with NIS2 incurs fines up to €10 million or 2% of total global annual turnover for essential entities, and up to €7 million or 1.4% for important entities, plus potential business suspension and personal liability for senior management. National authorities enforce via spot checks, with transposition into member state laws effective from October 18, 2024, emphasizing board-level accountability for cybersecurity failures.

An NIS2 be mapped to other international frameworks?

Yes, EU member states incorporate standards like ISO 27001, NIST CSF, and ENISA guidelines into national NIS2 frameworks to facilitate mapping and compliance. This alignment supports implementation of required risk management, supply chain security, and incident handling without direct certification mandates.

What is the first step to begin implementing NIS2?

The first step for NIS2 implementation is to determine applicability by assessing entity size, sector, and criticality against the size-cap rule and registering with national authorities. This involves compiling organization details, contact information, sector classification, and member state operations, followed by establishing governance with senior management oversight and baseline risk assessments.

What is the primary objective of GMP?

GMP establishes minimum standards for manufacturing controls to ensure products are consistently produced and controlled to meet predefined quality criteria. It prevents contamination, mix-ups, mislabeling, and process variability through preventive systems like validated processes, independent quality oversight, and the "5 Ps" (People, Products, Procedures, Processes, Premises), rather than relying solely on final testing.

Who is legally or professionally required to comply with GMP?

GMP compliance is legally required for manufacturers of pharmaceuticals, biologics, APIs, and related products under FDA 21 CFR Parts 210/211, EU EudraLex Volume 4, and WHO GMP. This includes contract manufacturers (CMOs), suppliers of starting materials, and organizations exporting to regulated markets; the sponsor remains accountable for outsourced activities via quality agreements and audits.

Does GMP require an external audit or third-party certification?

GMP does not mandate third-party certification but requires regular regulatory inspections by authorities like FDA or EMA, plus internal audits and self-inspections. PIC/S and MRAs enable mutual recognition, but operators must maintain inspection readiness through independent quality units and documented programs.

How often should an assessment for GMP be performed?

GMP assessments, including internal audits and self-inspections, must be conducted at planned intervals based on risk, typically annually with more frequent reviews for high-risk areas. Product Quality Reviews occur annually (21 CFR §211.180(e)), and continual monitoring via CAPA, change control, and management review ensures ongoing state of control.

What are the consequences of non-compliance with GMP?

Non-compliance with GMP triggers regulatory actions including Form 483 observations, Warning Letters, import alerts, recalls, fines up to $50k per day (FDA), production halts, and potential criminal liability. Historical cases like Elixir Sulfanilamide demonstrate patient harm, market exclusion, and multimillion-dollar remediation costs.

An GMP be mapped to other international frameworks?

Yes, GMP aligns closely with ICH Q7 (API), Q9 (QRM), Q10 (PQS), PIC/S, and WHO guidelines through harmonized principles like quality systems, validation, and risk management. Regional variations (e.g., EU QP under Annex 16) exist, but MRAs reduce duplication for global operations.

What is the first step to begin implementing GMP?

The first step is conducting a comprehensive gap analysis against applicable regulations (e.g., 21 CFR Part 211, EU GMP) to identify deficiencies in the 5 Ps, followed by developing a Validation Master Plan (VMP). This prioritizes remediation, secures executive sponsorship, and establishes a risk-based roadmap.

Standards Comparison

NIS2 vs GMP

NIS2

Mandatory

2022

EU directive for cybersecurity resilience in critical sectors

GMP

Mandatory

1963

Regulatory framework for consistent manufacturing quality controls.

Quick Verdict

NIS2 mandates cybersecurity resilience for EU critical sectors via risk management and rapid incident reporting, while GMP enforces manufacturing quality controls through validation and documentation. Companies adopt NIS2 for regulatory compliance and cyber defense; GMP ensures product safety and market access.

Cybersecurity

NIS2

Network and Information Systems Directive 2 (NIS2)

Cost

€€€€

Complexity

High

Implementation Time

12-18 months

Key Features

Expands scope via size-cap rule to medium/large entities
Mandates 24-hour early warning incident reporting
Holds senior management directly accountable for compliance
Imposes fines up to 2% global annual turnover
Requires continuous risk management and supply chain security

Manufacturing Quality

GMP

Good Manufacturing Practices (GMP)

Cost

€€€

Complexity

Medium

Implementation Time

18-24 months

Key Features

Independent quality unit oversight and batch release
Risk-based Quality Risk Management (QRM) principles
Process and equipment validation (IQ/OQ/PQ)
Comprehensive documentation and data integrity (ALCOA++)
Continual improvement via CAPA and audits

Detailed Analysis

A comprehensive look at the specific requirements, scope, and impact of each standard.

NIS2 Details

What It Is

NIS2 Directive (EU) 2022/2555 is an EU regulation replacing the original NIS Directive. It establishes a high common level of cybersecurity across member states, expanding scope to more sectors like energy, transport, and digital services. Applies to essential and important entities via size-cap rule (medium/large organizations). Employs a risk-based, all-hazards approach for resilience.

Key Components

Four pillars: risk management, incident reporting, business continuity, corporate accountability.
Strict reporting: 24-hour early warning, 72-hour notification, 1-month final report to CSIRTs.
Continuous measures: supply chain security, access controls, encryption.
Builds on standards like ISO 27001, NIST CSF; no formal certification but national enforcement.

Why Organizations Use It

Mandatory compliance avoids fines up to 2% global turnover.
Enhances cyber resilience against threats like ransomware, APTs.
Builds stakeholder trust, ensures business continuity.
Strategic benefits: harmonized EU-wide cooperation, competitive edge in critical sectors.

Implementation Overview

EU states transposed by October 2024; 12-18 month grace periods in some.
Targets medium/large entities in covered sectors EU-wide.
Involves risk assessments, training, governance, audits.
Proactive: dynamic registers, spot checks, board oversight. (178 words)

GMP Details

What It Is

Good Manufacturing Practice (GMP) is a regulatory framework establishing minimum standards for manufacturing controls in pharmaceuticals, biologics, and related products. Its primary purpose is to ensure products are consistently produced to quality criteria, preventing contamination, mix-ups, and variability through preventive systems rather than end-testing alone. It adopts a risk-based approach via Quality Risk Management (QRM) and Pharmaceutical Quality Systems (PQS).

Key Components

Core pillars: 5 Ps (People, Premises, Processes, Procedures, Products)
Elements include quality management, personnel training, facility design, equipment validation, documentation, supplier controls, and continual improvement (CAPA, audits)
Built on ICH Q9/Q10, FDA 21 CFR 210/211, EU EudraLex Volume 4, WHO GMP
Compliance via inspections, no central certification but enforceable legally

Why Organizations Use It

GMP is mandatory for regulated industries to meet legal requirements, protect patients, avoid recalls/fines, and secure market access. It reduces risks, enhances efficiency, builds stakeholder trust, and supports global supply chains via harmonization (PIC/S, MRAs).

Implementation Overview

Phased approach: gap analysis, QMS design, validation (IQ/OQ/PQ), training, audits. Applies to manufacturers globally; intensive for pharma/biologics, scalable by size. Requires ongoing audits/inspections.

Key Differences

Aspect	NIS2	GMP
Scope	Cybersecurity risk management, incident reporting, governance	Manufacturing controls, quality systems, process validation
Industry	Essential/important entities in EU sectors like energy, transport	Pharmaceuticals, biologics, food, cosmetics globally
Nature	Mandatory EU directive with national transposition	Regulatory standards enforced by FDA, EMA, WHO
Testing	Incident reporting timelines, risk assessments	Process/equipment validation, IQ/OQ/PQ, audits
Penalties	Up to 2% global turnover or €10M fines	Warning letters, recalls, import bans, fines

Scope

NIS2

Cybersecurity risk management, incident reporting, governance

GMP

Manufacturing controls, quality systems, process validation

Industry

NIS2

Essential/important entities in EU sectors like energy, transport

GMP

Pharmaceuticals, biologics, food, cosmetics globally

Nature

NIS2

Mandatory EU directive with national transposition

GMP

Regulatory standards enforced by FDA, EMA, WHO

Testing

NIS2

Incident reporting timelines, risk assessments

GMP

Process/equipment validation, IQ/OQ/PQ, audits

Penalties

NIS2

Up to 2% global turnover or €10M fines

GMP

Warning letters, recalls, import bans, fines

Frequently Asked Questions

Common questions about NIS2 and GMP

NIS2 FAQ

GMP FAQ

You Might also be Interested in These Articles...

Unpacking the True Cost: A Guide to Calculating TCO for Modern Compliance Monitoring Software

Unpack the true Total Cost of Ownership (TCO) for compliance monitoring software. Factor in licenses, implementation, training, maintenance, and ROI savings for

CIS Controls v8.1, Operationalized: Top 10 Reasons Compliance Monitoring Software Accelerates Real-World Implementation

Operationalize CIS Controls v8.1 with compliance monitoring software. Turn checklists into dashboards, tickets, and audit-proof workflows. Top 10 reasons it acc

Why applying the NIST CSF Standard is a Life-Saver!

Discover why NIST CSF 2.0 is a life-saver for organizations. This flexible framework's 6 functions—Govern, Identify, Protect, Detect, Respond, Recover—boost res

Run Maturity Assessments with GRADUM

Transform your compliance journey with our AI-powered assessment platform

Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

100+ Standards & Regulations

AI-Powered Insights

Collaborative Assessments

Actionable Recommendations

Explore More Comparisons

See how NIS2 and GMP compare against other standards

Other NIS2 Comparisons

Other GMP Comparisons

Quick Verdict

What It Is

Key Components

Four pillars: risk management, incident reporting, business continuity, corporate accountability.

Strict reporting: 24-hour early warning, 72-hour notification, 1-month final report to CSIRTs.

Continuous measures: supply chain security, access controls, encryption.

Builds on standards like ISO 27001, NIST CSF; no formal certification but national enforcement.

What It Is

Key Components

Core pillars: 5 Ps (People, Premises, Processes, Procedures, Products)

Elements include quality management, personnel training, facility design, equipment validation, documentation, supplier controls, and continual improvement (CAPA, audits)

Built on ICH Q9/Q10, FDA 21 CFR 210/211, EU EudraLex Volume 4, WHO GMP

Compliance via inspections, no central certification but enforceable legally

Aspect

NIS2

GMP

Scope

Cybersecurity risk management, incident reporting, governance

Manufacturing controls, quality systems, process validation

Industry

Essential/important entities in EU sectors like energy, transport

Pharmaceuticals, biologics, food, cosmetics globally

Nature

Mandatory EU directive with national transposition

Regulatory standards enforced by FDA, EMA, WHO

Testing

Incident reporting timelines, risk assessments

Process/equipment validation, IQ/OQ/PQ, audits

Penalties

Up to 2% global turnover or €10M fines

Warning letters, recalls, import bans, fines